{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:32:08Z","timestamp":1773401528156,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007416","name":"Japan Health Sciences Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejphar.2021.174099","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T18:08:24Z","timestamp":1619374104000},"page":"174099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Examination of the antiepileptic effects of valacyclovir using kindling mice\u2015 search for novel antiepileptic agents by drug repositioning using a large medical information database"],"prefix":"10.1016","volume":"902","author":[{"given":"Shimon","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshi","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Jozukuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Niimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-283X","authenticated-orcid":false,"given":"Masayuki","family":"Chuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-1479","authenticated-orcid":false,"given":"Mitsuhiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Zamami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Izawa-Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-5943","authenticated-orcid":false,"given":"Masaki","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-2262","authenticated-orcid":false,"given":"Hiroaki","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174099_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2021.174099_bib2","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","article-title":"Differential expression of synaptic vesicle protein 2 (SV2) isoforms","volume":"14","author":"Bajjalieh","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174099_bib3","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1073\/pnas.90.6.2150","article-title":"Brain contains two forms of synaptic vesicle protein 2","volume":"90","author":"Bajjalieh","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174099_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174099_bib5","first-page":"32","article-title":"Analysis of synaptotagmin, SV2, and Rab3 expression in cortical glutamatergic and GABAergic axon terminals","volume":"5","author":"Bragina","year":"2011","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174099_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2008.01.032","article-title":"Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats","volume":"434","author":"De Almeida Rabello Oliveira","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174099_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12031-009-9288-2","article-title":"Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy","volume":"39","author":"Feng","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174099_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.00944.2004","article-title":"Furosemide and mannitol suppression of epileptic activity in the human brain","volume":"94","author":"Haglund","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2021.174099_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2012.06.058","article-title":"Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure","volume":"221","author":"Hanaya","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174099_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(96)00021-4","article-title":"Activation of c-fos in the brain","volume":"50","author":"Herrera","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174099_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.270.5233.99","article-title":"Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity","volume":"270","author":"Hochman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174099_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.2850","article-title":"GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy","volume":"18","author":"Koyama","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2021.174099_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2021.174099_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-198308030-00001","article-title":"Clinical pharmacokinetics of acyclovir","volume":"8","author":"Laskin","year":"1983","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2021.174099_bib16","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174099_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2021.174099_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.03.009","article-title":"Kindling and status epilepticus models of epilepsy: rewiring the brain","volume":"73","author":"Morimoto","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174099_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2009.09.035","article-title":"Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazol kindling","volume":"390","author":"Ohno","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174099_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2012.01.009","article-title":"Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus","volume":"510","author":"Ohno","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174099_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2021.174099_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.017","article-title":"Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants","volume":"673","author":"Takechi","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174099_bib23","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1128\/AAC.02862-14","article-title":"Convulsive liability of cefepime and meropenem in normal and corneal kindled mice","volume":"58","author":"Tanaka","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.174099_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1528-1167.2008.01955.x","article-title":"Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers","volume":"50","author":"Toering","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174099_bib25","doi-asserted-by":"crossref","first-page":"27420","DOI":"10.1038\/srep27420","article-title":"Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission","volume":"6","author":"Tokudome","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174099_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1528-1167.2008.01727.x","article-title":"Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy","volume":"50","author":"Van Vliet","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174099_bib27","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/ph3072090","article-title":"Difficulties in treatment and management of epilepsy and challenges in new drug development","volume":"3","author":"Wahab","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2021.174099_bib32","doi-asserted-by":"crossref","unstructured":"Y. Watanabe, Y. Kaida, S. Fukuhara, K. Takechi, T. Uehara, C. Kamei Participation of metabotropic glutamate receptors in pentetrazol-induced kindled seizure Epilepsia, 52 (2011), pp. 140-150.","DOI":"10.1111\/j.1528-1167.2010.02764.x"},{"key":"10.1016\/j.ejphar.2021.174099_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2004.05.010","article-title":"Valacyclovir treatment ameliorates the persistently increased pentylenetetrazol-induced seizure susceptibility in mice with herpes simplex virus type 1 infection","volume":"189","author":"Wu","year":"2004","journal-title":"Exp. Neurol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921002521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:51:08Z","timestamp":1757976668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921002521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"alternative-id":["S0014299921002521"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174099","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examination of the antiepileptic effects of valacyclovir using kindling mice\u2015 search for novel antiepileptic agents by drug repositioning using a large medical information database","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174099"}}